Welcome to LookChem.com Sign In | Join Free

Science Details

Home > Chemical Encyclopedia > Science List > Details
  • Lisinopril (cas 76547-98-3) inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis

  • Add time:07/12/2019    Source:sciencedirect.com

    Therapeutic interventions are still limited in the treatment of liver fibrosis even though an incredible number of publications related to silymarin are produced. This is due to the complex molecular pathogenesis. Several studies pointed to the role of renin-angiotensin system (RAS) in hepatic fibrogenesis. Therefore, the present study was designed to examine the effect of the combination of Lisinopril (cas 76547-98-3) (LIS) with silymarin (SIL) on CCl4-induced hepatic fibrosis along with an in-vitro confirmatory experiment. Rats were treated with LIS (1 mg kg−1) and SIL (30 mg kg−1) as a single agent and as combined to LIS (1 mg kg−1). Our results revealed that down-regulation of NFĸBp65 mRNA expression and inhibition of phosphorylation of NFĸBp65 (at Ser536) and NFĸBia were implicated in the anti-fibrotic effect of both LIS and SIL. Consequently lower levels of NFкB-induced TNF-α, TGF-β1, MMP-2, TIMP-1 and VEGF compared to control group. In addition, levels of α-SMA protein expression and hydroxyproline are decreased in association with marked improvement in liver function, oxidative stress markers and histological picture. In addition, LIS augmented the inhibitory effect of SIL on NFĸB pathway at lower dose level. We concluded that LIS, via targeting NFĸB pathway, increases anti-oxidant capacity of liver tissue and exhibits anti-inflammatory, anti-fibrotic and anti-angiogenic activity and augments sensitivity to SIL. Therefore, LIS is a promising candidate for further clinical investigation in the treatment of liver fibrosis.

    We also recommend Trading Suppliers and Manufacturers of Lisinopril (cas 76547-98-3). Pls Click Website Link as below: cas 76547-98-3 suppliers

    Prev:Randomized Trial of Lisinopril (cas 76547-98-3) Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
    Next:Effect of amlodipine, Lisinopril (cas 76547-98-3) and allopurinol on acetaminophen-induced hepatotoxicity in rats)

  • Back】【Close 】【Print】【Add to favorite
Periodic Table
    Related Products